Protection Analysis

Panacea community - Protection sales by quarter

Product Q1 18 Q2 18 Q3 18 Q4 18 TOTAL
Crit. Illness £1,092,645 £1,222,727 £1,185,898 £3,597,211 £7,098,480
Decreasing Term with CI £3,995,935 £4,075,406 £4,107,786 £3,510,068 £15,689,195
Income Prot. £2,969,476 £3,083,924 £3,175,175 £5,077,267 £14,305,842
Mortgage Term £7,542,726 £7,926,155 £8,011,722 £7,428,881 £30,909,484
Relevant Life £1,998,531 £2,062,190 £1,810,842 £1,967,155 £7,838,718
Term £18,710,267 £18,541,949 £17,766,057 £16,532,213 £71,550,486
Term with Critical Illness £5,699,832 £5,735,280 £5,282,554 £5,267,923 £21,985,589
Whole of Life £5,656,092 £4,772,647 £5,192,101 £3,999,635 £19,620,474
Grand total £47,665,503 £47,420,279 £46,532,134 £47,380,353 £188,998,268

 

2018 total Protection sales

Product Non-user Sales (£) Panacea Community Sales (£) TOTAL Market Share
Crit. Illness £15,192,692 £7,098,480 £22,291,172 32%
Decreasing Term with CI £39,501,907 £15,689,195 £55,191,102 28%
Income Prot. £28,412,191 £14,305,842 £42,718,033 33%
Mortgage Term £73,776,674 £30,909,484 £104,686,157 30%
Relevant Life £11,064,933 £7,838,718 £18,903,651 41%
Term £156,378,516 £71,550,486 £227,929,001 31%
Term with Critical Illness £60,241,482 £21,985,589 £82,227,071 27%
Whole of Life £25,045,001 £19,620,474 £44,665,475 44%
Grand total £409,613,394 £188,998,268 £598,611,663 32%

   

Please contact sarahpaul@panaceaadviser.com if you are interested in speaking to us further.

Email this article Print Share on Twitter Share on LinkedIn Share on Facebook Share on Google+